Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Summary 
Currently, Sapna R. Srivastava holds the position of Chief Financial & Strategy Officer at eGenesis, Inc.

She is also Strategic Advisor at BioPlus Acquisition Corp. and on the board of 6 other companies.

She previously held the position of Chief Financial & Strategy Officer at Intellia Therapeutics, Inc., Chief Financial & Strategy Officer at Abide Therapeutics, Inc., Research Analyst at Morgan Stanley & Co. LLC, Analyst at Goldman Sachs & Co. LLC and Analyst at Thomas Weisel Partners LLC.

She received a doctorate from New York University and an undergraduate degree from St. Xavier's College (Mumbai).


Current positions of Sapna R. Srivastava 
NameTitle Since
Nuvalent, Inc.
(Biotechnology & Medical Research)
Independent Director 2021
Talaris Therapeutics, Inc.
(Biotechnology & Medical Research)
Independent Director 2021
SQZ Biotechnologies Company
(Biotechnology & Medical Research)
Independent Director 2020
Social Capital Suvretta Holdings Corp. II
(Investment Holding Companies)
Independent Director -
eGenesis, Inc. Chief Financial & Strategy Officer 2021
Aura Biosciences, Inc. Director 2021
AsclepiX Therapeutics LLC Director 2019
BioPlus Acquisition Corp. Strategic Advisor -


Holdings of Sapna R. Srivastava 
NameEquities%Valuation
SQZ Biotechnologies Company (SQZ)
(Biotechnology & Medical Research)
00.0000%0 USD
Talaris Therapeutics, Inc. (TALS)
(Biotechnology & Medical Research)
00.0000%0 USD


Sapna R. Srivastava: Personal Network 
Most Read News 
09/22WILLIAM ACKMAN : Ackman's Pershing Square fund surges as Universal soars in stock debut
RE
09/14BRAD SMITH : Microsoft to buy back up to $60 billion in shares; names Brad Smith vice chair
RE
09/13MARTIN SORRELL : Sorrell's S4 Capital raises annual profit outlook for a third time
RE
09/24CATHIE WOOD : Chinese crackdown on bitcoin another blow to Cathie Wood's ARK ETF
RE
09/14CATHIE WOOD : ARK Invest's Wood expects market rotation back to growth stocks
RE
09/22CATHIE WOOD : ARK's Cathie Wood says Wall Street not in a bubble
RE
09/24ELON MUSK : New semiconductor plants will end global auto chip shortage next year -Tesla's Musk
RE
09/21JEFF BEZOS : UK's Johnson discussed taxation with Amazon's Bezos
RE
09/17STELIOS HAJI-IOANNOU : EasyJet shareholder Stelios Haji-Ioannou shuns rights issue -source
RE
09/24BARRY DILLER : Stock Futures Weaken After Evergrande Payment Deadline Passes
DJ
More news


© 2021 People and Ownership :   
Sapna R. Srivastava : Connections